Higen RNM Co Ltd

The company's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position. However, the liquidity position is mixed: while the company holds KRW 22.7 billion in cash and equivalents, its operating cash flow is negative at KRW -9.7 billion, and free cash flow is also negative at KRW -10.2 billion. The current ratio of 2.77 suggests the company has sufficient short-term assets to cover its liabilities, but the negative net cash position after subtracting total debt raises concerns about near-term liquidity.

Profitability metrics are weak, with a return on equity (ROE) of -6.65% and a return on assets (ROA) of -4.24%. The company reported a net loss of KRW 7.1 billion and an operating loss of KRW 9.3 billion in the latest period. Gross profit of KRW 3.1 billion is minimal relative to revenue of KRW 73.5 billion, indicating low margins and potential pricing or cost control issues.

The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification reported. This lack of diversification increases exposure to sector-specific risks and regional economic fluctuations.

Growth prospects are muted, with no specific revenue growth targets provided in the latest financial disclosures. The company's capital expenditure of KRW -5.3 billion suggests a reduction in investment, which may reflect a strategic shift or financial constraints. Analysts have assigned a "Hold" recommendation, with a mean price target of KRW 55,000, implying limited upside potential from the current market price of KRW 38,000.

The risk profile is elevated due to negative operating and free cash flows, as well as a net loss. The company's liquidity risk is rated as medium, and while dilution risk is currently low, the negative cash flow and operating performance could necessitate future equity or debt financing. No recent filings or transcripts have been disclosed that would indicate material changes in the company's strategic direction or operational performance.

Recent analyst estimates suggest a cautious outlook, with no strong buy or buy ratings and a single hold recommendation. The consensus price target of KRW 55,000 implies a potential upside of 47.37% from the current market price, but the lack of strong buy ratings suggests limited conviction in the company's near-term recovery.